Healthcare provider profile · identity verified

Michael T Csaszar, MD

Family Practice · CANBY, OR · NPI 1699901355

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1069	281
Levothyroxine Sodium	Levothyroxine Sodium	523	141
Lisinopril	Lisinopril	446	123
Amlodipine Besylate	Amlodipine Besylate	440	125
Losartan Potassium	Losartan Potassium	429	115
Omeprazole	Omeprazole	337	105
Metoprolol Succinate	Metoprolol Succinate	307	85
Tamsulosin Hcl	Tamsulosin Hcl	269	72
Furosemide	Furosemide	258	72
Hydrochlorothiazide	Hydrochlorothiazide	247	73
Trazodone Hcl	Trazodone Hcl	237	78
Eliquis	Apixaban	221	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	221	44
Gabapentin	Gabapentin	184	57
Albuterol Sulfate Hfa	Albuterol Sulfate	179	67
Montelukast Sodium	Montelukast Sodium	171	49
Simvastatin	Simvastatin	170	49
Escitalopram Oxalate	Escitalopram Oxalate	168	44
Metformin Hcl	Metformin Hcl	157	49
Ozempic	Semaglutide	142	26
Sertraline Hcl	Sertraline Hcl	134	34
Metformin Hcl Er	Metformin Hcl	133	42
Allopurinol	Allopurinol	130	36
Oxycodone Hcl	Oxycodone Hcl	130	49
Metoprolol Tartrate	Metoprolol Tartrate	126	34
Potassium Chloride	Potassium Chloride	124	39
Pantoprazole Sodium	Pantoprazole Sodium	109	34
Glipizide Er	Glipizide	105	29
Jardiance	Empagliflozin	99	24
Prednisone	Prednisone	97	66
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	26
Pravastatin Sodium	Pravastatin Sodium	96	28
Rosuvastatin Calcium	Rosuvastatin Calcium	95	30
Carvedilol	Carvedilol	91	30
Clopidogrel	Clopidogrel Bisulfate	86	28
Bupropion Xl	Bupropion Hcl	84	21
Lovastatin	Lovastatin	83	26
Finasteride	Finasteride	79	24
Myrbetriq	Mirabegron	77	19
Citalopram Hbr	Citalopram Hydrobromide	72	18
Ezetimibe	Ezetimibe	72	21
Atenolol	Atenolol	70	18
Mirtazapine	Mirtazapine	70	20
Glipizide	Glipizide	69	20
Meloxicam	Meloxicam	66	36
Enalapril Maleate	Enalapril Maleate	65	16
Duloxetine Hcl	Duloxetine Hcl	64	20
Spironolactone	Spironolactone	63	20
Tramadol Hcl	Tramadol Hcl	63	19
Warfarin Sodium	Warfarin Sodium	63	13
Alendronate Sodium	Alendronate Sodium	62	16
Methocarbamol	Methocarbamol	62	16
Tizanidine Hcl	Tizanidine Hcl	62	21
Quetiapine Fumarate	Quetiapine Fumarate	61	12
Solifenacin Succinate	Solifenacin Succinate	59	18
Lorazepam	Lorazepam	58	20
Zolpidem Tartrate	Zolpidem Tartrate	58	19
Alprazolam	Alprazolam	55	13
Clonazepam	Clonazepam	53	suppressed
Ondansetron Odt	Ondansetron	53	28
Trulicity	Dulaglutide	53	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Benazepril Hcl	Benazepril Hcl	45	12
Cephalexin	Cephalexin	44	32
Pioglitazone Hcl	Pioglitazone Hcl	44	14
Doxazosin Mesylate	Doxazosin Mesylate	43	13
Fluoxetine Hcl	Fluoxetine Hcl	43	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	12
Ropinirole Hcl	Ropinirole Hcl	42	13
Propranolol Hcl	Propranolol Hcl	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Glimepiride	Glimepiride	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Baclofen	Baclofen	37	13
Rybelsus	Semaglutide	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	12
Venlafaxine Hcl Er	Venlafaxine Hcl	36	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	24
Azithromycin	Azithromycin	33	25
Donepezil Hcl	Donepezil Hcl	33	11
Risedronate Sodium	Risedronate Sodium	32	11
Levetiracetam	Levetiracetam	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	29	23
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	21
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	11
Estradiol	Estradiol	23	suppressed
Famotidine	Famotidine	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	19
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Chlorthalidone	Chlorthalidone	21	suppressed
Amoxicillin	Amoxicillin	20	suppressed
Diazepam	Diazepam	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Levofloxacin	Levofloxacin	17	15
Primidone	Primidone	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	12
Clobetasol Propionate	Clobetasol Propionate	16	13
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nystatin	Nystatin	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Fluconazole	Fluconazole	14	11
Glycopyrrolate	Glycopyrrolate	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Metaxalone	Metaxalone	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Temazepam	Temazepam	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error